Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

North America Sleep Apnea Therapeutics and Diagnostics Market Forecast 2021-2028

Published by Inkwood Research Product code 1018668
Published Content info 164 Pages
Delivery time: 2-3 business days
Price
Back to Top
North America Sleep Apnea Therapeutics and Diagnostics Market Forecast 2021-2028
Published: July 19, 2021 Content info: 164 Pages
Description

KEY FINDINGS

The North America sleep apnea therapeutics and diagnostics market growth is estimated to progress at a CAGR of 6.10% during the forecast period, 2021-2028. The growing demand for portable sleep apnea devices and technological advancements in the sleep apnea devices and platforms propel market growth.

MARKET INSIGHTS

Canada and the United States are assessed for the North America sleep apnea therapeutics and diagnostics market growth analysis. In Canada, the sleep apnea prevalence is moderate. The market growth is attributed to the growing demand for PAP devices. The emerging sleep apnea devices and platforms industry is primarily dependent on conventional sleep apnea devices. However, the unequal access to treatment, partial reimbursement, and lack of funds for research, restrict the technology integration in the sleep apnea devices. Also, the adoption of remote patient assessment devices is hindered due to the exclusion of home sleep testing from reimbursement.

Furthermore, the pandemic impact has negatively impacted the clinical diagnosis of sleep apnea. As per the statement by the Canadian Thoracic Society published on April 2020, clinical visits have been discontinued, available only in the case of an emergency.

COMPETITIVE INSIGHTS

Some of the prominent market players include: Invacare Corporation, Cadwell Industries Inc, Smiths Medical Inc, Itamar Medical Ltd, ResMed Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 24172

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. SURGING AGING POPULATION AND OBESITY
    • 3.1.2. AWARENESS OF ILL EFFECTS OF UNTREATED SLEEP APNEA
    • 3.1.3. SLEEP APNEA INCIDENCES
    • 3.1.4. DEMAND FOR PORTABLE SLEEP APNEA DEVICES
    • 3.1.5. TECHNOLOGICAL ADVANCEMENTS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. HIGH COST OF SLEEP APNEA DEVICES
    • 3.2.2. LACK OF REIMBURSEMENTS
    • 3.2.3. DEARTH OF PATIENT COMPLIANCE

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. REGULATORY FRAMEWORK
  • 4.5. SUPPLY CHAIN ANALYSIS
  • 4.6. OPPORTUNITY MATRIX
  • 4.7. VENDOR LANDSCAPE

5. MARKET BY PRODUCT TYPE

  • 5.1. THERAPEUTICS
    • 5.1.1. POSITIVE AIRWAY PRESSURE (PAP) DEVICES
    • 5.1.2. OXYGEN DEVICES
    • 5.1.3. MASKS AND ACCESSORIES
    • 5.1.4. ORAL APPLIANCES
    • 5.1.5. ADAPTIVE SERVO VENTILATION (ASV) DEVICES
  • 5.2. DIAGNOSTICS AND MONITORING
    • 5.2.1. POLYSOMNOGRAPHY DEVICE (PSG)
    • 5.2.2. OXIMETER
    • 5.2.3. ACTIGRAPHY MONITORING DEVICE
    • 5.2.4. RESPIRATORY POLYGRAPH
    • 5.2.5. SLEEP APNEA SCREENING DEVICE
    • 5.2.6. OTHER DIAGNOSTICS AND MONITORING DEVICES

6. MARKET BY END-USER

  • 6.1. HOSPITALS & SLEEP LABORATORIES
  • 6.2. HOME CARE SETTINGS

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. MARKET SIZE & ESTIMATES
    • 7.1.2. KEY GROWTH ENABLERS
    • 7.1.3. KEY CHALLENGES
    • 7.1.4. KEY PLAYERS
    • 7.1.5. COUNTRY ANALYSIS
      • 7.1.5.1. UNITED STATES
      • 7.1.5.2. CANADA

8. COMPETITIVE LANDSCAPE

  • 8.1. KEY STRATEGIC DEVELOPMENTS
    • 8.1.1. MERGERS & ACQUISITIONS
    • 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 8.1.3. PARTNERSHIPS & AGREEMENTS
    • 8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
  • 8.2. COMPANY PROFILES
    • 8.2.1. BMC MEDICAL CO LTD
    • 8.2.2. BRAEBON MEDICAL CORPORATION
    • 8.2.3. CADWELL INDUSTRIES INC
    • 8.2.4. DEVILBISS HEALTHCARE LLC
    • 8.2.5. FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
    • 8.2.6. GE HEALTHCARE
    • 8.2.7. INVACARE CORPORATION
    • 8.2.8. ITAMAR MEDICAL LTD
    • 8.2.9. KONINKLIJKE PHILIPS NV
    • 8.2.10. MEDTRONIC PLC
    • 8.2.11. NIHON KOHDEN CORPORATION
    • 8.2.12. RESMED INC
    • 8.2.13. SMITHS MEDICAL INC
    • 8.2.14. SOMNOMEDICS GMBH
    • 8.2.15. TELEFLEX INCORPORATED
    • 8.2.16. VYAIRE MEDICAL INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS
  • TABLE 2: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: NORTH AMERICA THERAPEUTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: NORTH AMERICA THERAPEUTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: NORTH AMERICA DIAGNOSTICS AND MONITORING MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: NORTH AMERICA DIAGNOSTICS AND MONITORING MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: LEADING PLAYERS OPERATING IN NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
  • TABLE 13: LIST OF MERGERS & ACQUISITIONS
  • TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 15: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 16: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: ADVANTAGES OF PORTABLE CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES
  • FIGURE 2: KEY INVESTMENT INSIGHTS
  • FIGURE 3: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, IN 2020
  • FIGURE 7: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY THERAPEUTICS, 2021-2028 (IN $ MILLION)
  • FIGURE 8: NORTH AMERICA SLEEP APNEA THERAPEUTICS MARKET, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 9: NORTH AMERICA SLEEP APNEA THERAPEUTICS MARKET, BY OXYGEN DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 10: NORTH AMERICA SLEEP APNEA THERAPEUTICS MARKET, BY MASKS AND ACCESSORIES, 2021-2028 (IN $ MILLION)
  • FIGURE 11: NORTH AMERICA SLEEP APNEA THERAPEUTICS MARKET, BY ORAL APPLIANCES, 2021-2028 (IN $ MILLION)
  • FIGURE 12: NORTH AMERICA SLEEP APNEA THERAPEUTICS MARKET, BY ADAPTIVE SERVO VENTILATION (ASV) DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 13: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY DIAGNOSTICS AND MONITORING, 2021-2028 (IN $ MILLION)
  • FIGURE 14: NORTH AMERICA DIAGNOSTICS AND MONITORING MARKET, BY POLYSOMNOGRAPHY DEVICE (PSG), 2021-2028 (IN $ MILLION)
  • FIGURE 15: NORTH AMERICA DIAGNOSTICS AND MONITORING MARKET, BY OXIMETER, 2021-2028 (IN $ MILLION)
  • FIGURE 16: NORTH AMERICA DIAGNOSTICS AND MONITORING MARKET, BY ACTIGRAPHY MONITORING DEVICE, 2021-2028 (IN $ MILLION)
  • FIGURE 17: NORTH AMERICA DIAGNOSTICS AND MONITORING MARKET, BY RESPIRATORY POLYGRAPH, 2021-2028 (IN $ MILLION)
  • FIGURE 18: NORTH AMERICA DIAGNOSTICS AND MONITORING MARKET, BY SLEEP APNEA SCREENING DEVICE, 2021-2028 (IN $ MILLION)
  • FIGURE 19: NORTH AMERICA DIAGNOSTICS AND MONITORING MARKET, BY OTHER DIAGNOSTICS AND MONITORING DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 20: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY END-USER, IN 2020
  • FIGURE 21: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY HOSPITALS & SLEEP LABORATORIES, 2021-2028 (IN $ MILLION)
  • FIGURE 22: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY HOME CARE SETTINGS, 2021-2028 (IN $ MILLION)
  • FIGURE 23: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 24: UNITED STATES SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 25: CANADA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
Back to Top